Free Trial

Lemonade (LMND) Competitors

$23.42
+0.72 (+3.17%)
(As of 07/26/2024 ET)

LMND vs. FG, ACT, BWIN, OSCR, GSHD, SPNT, PLMR, FIHL, ALHC, and CLOV

Should you be buying Lemonade stock or one of its competitors? The main competitors of Lemonade include F&G Annuities & Life (FG), Enact (ACT), The Baldwin Insurance Group (BWIN), Oscar Health (OSCR), Goosehead Insurance (GSHD), SiriusPoint (SPNT), Palomar (PLMR), Fidelis Insurance (FIHL), Alignment Healthcare (ALHC), and Clover Health Investments (CLOV). These companies are all part of the "insurance" industry.

Lemonade vs.

F&G Annuities & Life (NYSE:FG) and Lemonade (NYSE:LMND) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking, media sentiment and dividends.

F&G Annuities & Life has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Lemonade has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500.

F&G Annuities & Life received 116 more outperform votes than Lemonade when rated by MarketBeat users. Likewise, 58.44% of users gave F&G Annuities & Life an outperform vote while only 30.23% of users gave Lemonade an outperform vote.

CompanyUnderperformOutperform
F&G Annuities & LifeOutperform Votes
142
58.44%
Underperform Votes
101
41.56%
LemonadeOutperform Votes
26
30.23%
Underperform Votes
60
69.77%

In the previous week, F&G Annuities & Life had 2 more articles in the media than Lemonade. MarketBeat recorded 4 mentions for F&G Annuities & Life and 2 mentions for Lemonade. Lemonade's average media sentiment score of 0.82 beat F&G Annuities & Life's score of -1.00 indicating that F&G Annuities & Life is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
F&G Annuities & Life
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lemonade
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

F&G Annuities & Life has a net margin of 4.85% compared to F&G Annuities & Life's net margin of -48.14%. Lemonade's return on equity of 13.22% beat F&G Annuities & Life's return on equity.

Company Net Margins Return on Equity Return on Assets
F&G Annuities & Life4.85% 13.22% 0.57%
Lemonade -48.14%-30.30%-13.36%

95.9% of F&G Annuities & Life shares are held by institutional investors. Comparatively, 80.3% of Lemonade shares are held by institutional investors. 1.8% of F&G Annuities & Life shares are held by insiders. Comparatively, 12.5% of Lemonade shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

F&G Annuities & Life presently has a consensus target price of $44.50, indicating a potential upside of 1.60%. Lemonade has a consensus target price of $18.86, indicating a potential downside of 19.48%. Given Lemonade's stronger consensus rating and higher possible upside, analysts plainly believe F&G Annuities & Life is more favorable than Lemonade.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
F&G Annuities & Life
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Lemonade
3 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

F&G Annuities & Life has higher revenue and earnings than Lemonade. Lemonade is trading at a lower price-to-earnings ratio than F&G Annuities & Life, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
F&G Annuities & Life$4.50B1.23-$58M$1.9622.35
Lemonade$429.80M3.84-$236.90M-$3.13-7.48

Summary

F&G Annuities & Life beats Lemonade on 14 of the 18 factors compared between the two stocks.

Get Lemonade News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMND and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMND vs. The Competition

MetricLemonadeFire, marine, & casualty insurance IndustryFinance SectorNYSE Exchange
Market Cap$1.60B$41.24B$9.92B$18.50B
Dividend YieldN/A5.27%6.62%3.51%
P/E Ratio-7.4814.3147.1825.04
Price / Sales3.841.893,593.2415.37
Price / CashN/A17.2617.2819.61
Price / Book2.312.022.595.08
Net Income-$236.90M$3.90B$1.02B$977.27M
7 Day Performance6.02%3.32%1.80%1.57%
1 Month Performance42.28%7.34%7.74%5.69%
1 Year Performance12.81%43.21%14.98%9.05%

Lemonade Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FG
F&G Annuities & Life
2.498 of 5 stars
2.50 / 5 stars
$42.88
-4.3%
$44.50
+3.8%
+70.0%$5.65B$4.50B21.881,165Gap Up
ACT
Enact
0 of 5 stars
0.00 / 5 stars
$33.71
-0.2%
$26.20
-22.3%
+25.2%$5.30B$1.15B8.32500Upcoming Earnings
News Coverage
BWIN
The Baldwin Insurance Group
1.2631 of 5 stars
1.26 / 5 stars
$40.85
-1.8%
$41.75
+2.2%
N/A$4.89B$1.22B-44.403,927News Coverage
OSCR
Oscar Health
2.4553 of 5 stars
2.46 / 5 stars
$15.90
+2.0%
$19.75
+24.2%
+102.3%$3.70B$5.86B-39.752,400Gap Up
GSHD
Goosehead Insurance
3.4278 of 5 stars
3.43 / 5 stars
$65.70
-2.6%
$74.60
+13.5%
+28.7%$2.56B$261.28M105.971,415Earnings Report
Analyst Forecast
News Coverage
SPNT
SiriusPoint
0 of 5 stars
0.00 / 5 stars
$13.73
-0.7%
N/A+51.0%$2.36B$2.74B8.171,063Upcoming Earnings
Short Interest ↑
PLMR
Palomar
3.5494 of 5 stars
3.55 / 5 stars
$89.02
-2.6%
$93.83
+5.4%
+51.6%$2.28B$375.93M25.58150Analyst Revision
FIHL
Fidelis Insurance
4.1423 of 5 stars
4.14 / 5 stars
$16.89
-1.7%
$20.00
+18.4%
+28.2%$2.03B$3.60B4.1077Short Interest ↓
ALHC
Alignment Healthcare
1.1961 of 5 stars
1.20 / 5 stars
$9.29
-2.6%
$9.11
-1.9%
+47.4%$1.78B$1.82B-11.061,536Upcoming Earnings
Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
CLOV
Clover Health Investments
0.5325 of 5 stars
0.53 / 5 stars
$1.60
-3.6%
$1.50
-6.3%
+51.8%$824.09M$2.03B-4.71680Gap Down

Related Companies and Tools

This page (NYSE:LMND) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners